DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Yurdaydin C, Idilman R, Keskin O. et al.
A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis – end of treatment results from the LOWR HDV-2 study.

Journal Of Hepatology 2017;
66: S33-S34

Download Bibliographical Data

Search in: